Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Industry performance is calculated based on the previous closing price of all industry constituents
Largest Companies in This Industry
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 178.78 | 218.58 | 44.67% | | | | Buy | |
| 11.60 | 15.52 | 7.64% | | | | Hold | |
| 120.27 | 160.92 | 6.70% | | | | Buy | |
| 58.60 | 60.75 | 5.87% | | | | Hold | |
| 84.75 | 98.77 | 4.94% | | | | Buy | |
| 109.84 | 144.55 | 4.21% | | | | Buy | |
| 12.64 | 18.83 | 3.45% | | | | Buy | |
| 25.70 | 32.62 | 2.30% | | | | Buy | |
| 12.98 | 20.25 | 2.16% | | | | Buy | |
| 73.75 | 81.33 | 2.02% | | | | Buy |
Investing in the Drug Manufacturers - Specialty & Generic Industry
Start Investing in Drug Manufacturers - Specialty & Generic Through These Companies
Top Performing Companies
View MoreName | Last Price | 1Y Target Est. | YTD Return |
|---|---|---|---|
| 45.06 | 59.45 | | |
| 9.06 | 8.00 | | |
| 5.49 | 9.56 | | |
| 23.12 | 16.80 | | |
| 8.47 | 13.00 | |
High Growth Companies
View MoreName | Last Price | Growth Estimate | YTD Return |
|---|---|---|---|
| 34.14 | | | |
| 5.75 | | | |
| 58.60 | | | |
| 8.47 | | | |
| 5.49 | | |
Drug Manufacturers - Specialty & Generic Research
View MoreDiscover the Latest Analyst and Technical Research for This Industry
Analyst Report: Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
RatingPrice TargetAnalyst Report: Haleon plc
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
RatingPrice TargetDaily – Vickers Top Insider Picks for 10/31/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 10/30/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
